TNF and inflammatory bowel disease: This finding led the authors to conclude that a single dose of COVID-19 is not enough to protect IBD patients receiving infliximab and that IBD patients, even in the presence of TNF blockade, should be prioritized for optimally timed second vaccine doses (62).